Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Young Chan Kim

BMBS BMedSci BSc MRes DPhil (Oxon)

Sir Henry Wellcome Fellow and Principal Investigator

  • Sir Henry Wellcome Fellow
  • Principal Investigator at Oxford Vaccine Group (OVG)
  • Research Fellow (RF) at Wolfson College
  • Lecturer in Medicine at Somerville College


I obtained a BSc degree in Biochemistry from Imperial College London and completed my medical degrees (BMBS, BMedSci and MRes) from the University of Nottingham. I then spent few years working in junior doctor posts before coming to Oxford to start a DPhil in Clinical Medicine.

My DPhil studies focused on vaccine development against arthropod-borne viruses supported by Innovate UK funding. I was awarded highly prestigious NDM Graduate Student Prize 2020 (Overall Prize Winner) for my overall performance during my DPhil at the Nuffield Department of Medicine (NDM).

In 2021, I received an NIHR Oxford BRC grant for my postdoctoral research and I was elected as a JRF Fellow at Wolfson College. I joined the Oxford Vaccine Group (OVG) as a Senior Postdoctoral Researcher in 2021 to lead the projects on enteric fever (typhoid and paratyphoid) and Q-fever. 

In 2022, I was awarded the Sir Henry Wellcome Fellowship to start my independent research on development of vaccines and therapeutics against arboviruses. Between 2022 and 2023, I received MRC HIC-VAC and MRC IAA grants to develop serological assays against enteric fever, as well as the MLSTF and MRC IAA grants to develop a novel vaccine against Chagas disease. 

After successfully securing three SBRI Innovate UK awards in 2023, I am now leading a group of postdocs, research assistants and DPhil students to develop new vaccines against Plague, Q fever, alphaviruses and the human challenge studies under the direction of Prof Sir Andrew Pollard. I was elected as a RF Fellow at Wolfson College in 2023.  

Currently, I am a Sir Henry Wellcome Fellow, Principal Investigator (PI) at OVG, RF Fellow at Wolfson College, Lecturer in Medicine at Somerville College, and Medical Doctor in Internal Medicine at the Oxford University Hospitals NHS Trust. 


My team within the Oxford Vaccine Group (OVG) is dedicated to developing novel vaccines against emerging infectious diseases, including Alphaviruses, Plague, Q fever, and Chagas

Additionally, a significant emphasis of my team lies in developing new diagnostic tools against infectious diseases such as Enteric fever (Salmonella Typhi/Paratyphi and Neglected Tropical Diseases (NTDs) suited for low-resource settings, ultimately aiming to improve clinical management and disease surveillance. 

We are regularly recruiting for motivated clinician, postdocs, research assistants and can supervise DPhil students from programmes at the University of Oxford. Please do not hesitate to contact me if you are interested in joining the group or collaborating with us.

DPhil Projects available

We are well-equipped to mentor and guide a diverse array of DPhil projects, encompassing both the development of new vaccines and diagnostic assays.

Any prospective students interested in pursuing a DPhil degree at the University of Oxford, especially within the area of our innovative vaccine development or diagnostic tools against emerging infectious diseases and neglected tropical diseases, are encouraged to visit the website below.